China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

CBPO 67.14 +1.30 (1.97%)
price chart
Update: China Biologic Products Q3 Earnings Beat (CBPO)
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Related articles »  
China Biologic Products Becomes Oversold (CBPO)
In trading on Monday, shares of China Biologic Products Inc (NASD: CBPO) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $49.11 per share.
Related articles »  
China Biologic Products, Inc. (CBPO) Rises: Stock Jumps 7.4%
China Biologic Products, Inc. (CBPO) was a big mover last session, as the company saw its shares rise more than 7% on the day.
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session ...  NASDAQ
Related articles »  
China Biologic Products Earnings Preview (CBPO)
After all, it seems that China remains largely untapped due to the lack of cultural awareness of Haemophilia. But, given that China Biologic Products is domestic to China, I suspect the company's efforts to improve cultural awareness could be effective.
Related articles »  
China Biologic Products' (CBPO) CEO David Gao on Q3 2014 Results ...
Hello, everyone and thank you for joining us on today's call. China Biologic announced its quarterly financial results on November 5 after the market closed.
Related articles »  
China Biologic to Build Two New Plasma Collection Stations in Hebei Province
BEIJING, Nov. 3, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary ...
Sector Update: Health Stocks Flat Pre-Bell  Nasdaq
Related articles »  
China Biologic Products (CBPO) CEO David Gao on Q2 2014 Results - Earnings ...
China Biologic Products (CBPO) CEO David Gao on Q2 2014 Results - Earnings Call Transcript. Aug. 10, 2014 10:18 PM ET | About: China Biologic Products, Inc. (CBPO) by: SA Transcripts. China Biologic Products, Inc. (NASDAQ:CBPO). Q2 2014 Earnings ...
Six Reasons to Buy China Biologic Products
China Biologic used to have only one operating subsidiary, Shandong Taibang. By the end of 2008, with the acquisition of Guiyang Dalin and a 35% equity interest in Xi'an Huitian, China Biologic became the largest non-state owned company in China's ...
Why China Biologic Products (CBPO) Could Be an Impressive Growth Stock
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors' attention, and produce big gains as well.
Related articles »  
China Biologic Products (CBPO) Adopts 'Poison Pill' Provision
China Biologic Products, Inc. (Nasdaq: CBPO) has adopted a stockholder rights plan. Pursuant to the plan, the Company will issue a dividend of one right for each share of its common stock held of record by stockholders as of the close of business on ...
Related articles »